Is it possible to abuse prozac

A Prozac addiction can still produce some unwanted physical reactions even though Prozac is considered to be physically non-addictive. Negative psychological withdrawal symptoms are also produced when someone with a Prozac dependency stops using.

Some of these signs felt from withdrawal are headaches, irritability, dizziness, moodiness, nausea, depression, muscle aches, insomnia and confused thinking.

There is very little information provided in relation to a Prozac addiction. However, as with all drugs, an addiction to fluoxetine is possible.

The key treatment for a Prozac addiction is to keep them calm and stress free. A Prozac treatment center would be most beneficial in dealing with the psychological dependency. Someone addicted to Prozac needs to seek help. They need to admit there is a problem and seek assistance. The first step to recovery and the most important is admitting there is a problem. The next crucial move is asking someone for help.

Help is out there for any and all addictions; admit there is a problem and take the first step toward recovery. I truly appreciate the information you all put out. Would love to see some info on that if available. The information contained on or provided through this service is intended for general consumer understanding and education and not as a substitute for medical or psychological advice, diagnosis, or treatment.

All information provided on the website is presented as is without any warranty of any kind, and expressly excludes any warranty of merchantability or fitness for a particular purpose. For those seeking addiction treatment for themselves or a loved one, the AddictionHope. Our helpline is offered at no cost to you and with no obligation to enter into treatment. Neither AddictionHope.

Seizure induced by insufflations of bupropion. N Engl J Med. Abuse potential of bupropion nasal insufflation: a case report. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Bupropion sustained release: a therapeutic overview.

Koob GF. Neurobiology of addiction. Textbook of Substance Abuse Treatment. Stahl SM. Essentials of Clinical Psychopharmacology. Prevalence of antidepressants and biosimilars in elite sport. Drug test. Manual of Clinical Psychopharmacology. Druteika D, Zed PJ. Cardiotoxicity following bupropion overdose. Ann Pharmacother. Krishnan KR. Monoamine oxidase inhibitors.

Tranylcypromine intoxication with malignant hyperthermia, delirium, and thrombocytopenia. Tranylcypromine withdrawal delirium. Nelson JC. Tricyclic and tetracyclic drugs. Abuse of amitriptyline. Baniewicz K. Case of amitriptyline abuse. Vasiliades J. Identification of misused drugs in the clinical laboratory. Clin Biochem. Delisle JD. A case of amitriptyline abuse. Am J Psychiatry. Wohlreich MM.

Amitriptyline abuse presenting as acute toxicity. Misuse of dothiepin. Deliberate misuse of tricyclic antidepressants by intravenous drug users — case studies and report. Scott Med J. Amitriptyline abuse and misuse. Am J Forensic Med Pathol. Tricyclic antidepressant abuse, with or without benzodiazepine abuse, in former heroin addicts currently in methadone maintenance treatment MMT Eur Neuropsychopharmacol.

Misuse of substances theoretically without abuse potential — case series. Przegl Lek. Shenouda R, Desan PH. Abuse of tricyclic antidepressant drugs. A case series. Richelson E. Tricyclic antidepressants and histamine H1 receptors. Mayo Clin Proc. Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse.

A case of venlafaxine abuse. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Two fatal cases of venlafaxine poisoning. J Anal Toxicol. Comparison of analytical methods in the determination of two venlafaxine fatalities.

Banham ND. Fatal venlafaxine overdose. Med J Aust. A mixed-drug intoxication involving venlafaxine and verapamil. J Forensic Sci. Fluoxetine dependence in a former amineptine abuser. Wilcox JA. Abuse of fluoxetine by a patient with anorexia nervosa. Fluoxetine abuse by an intravenous drug user. Fluoxetine abuse. Fluoxetine dependence and tolerance: a single case report. Ritualistic use of fluoxetine by a former substance abuser. Who develops severe or fatal adverse drug reactions to selective serotonin reuptake inhibitors?

Can J Psychiatry. Uzbekov MG. Antidepressant action of tianeptine is connected with acceleration of serotonin turnover in the synapse: a hypothesis. Neuropsychopharmacol Hung. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs. Wilde MI, Benfield P. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.

Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism. Is it possible to be dependent to tianeptine, an antidepressant?

A case reports. A case of tianeptine abuse. Turk Psikiyatri Derg. Abuse of tianeptine. Guillem E, Lepine JP. Does addiction to antidepressant exist? About a case of one addiction to tianeptine. Addictive potential of tianeptine — the threatening reality. Georgian Med News. Misuse of tianeptine: five cases of abuse. Ann Med Interne Paris ; :S58— Bilateral pseudoaneurysm secondary to intraarterial tianeptine abuse.

Anadolu Kardiyol Derg. Garattini S, Mennini T. Pharmacology of amineptine: synthesis and updating. Clin Neuropharmacol.

Garattini S. Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: a review. Int Clin Psychopharmacol.

Chronic amineptine abuse. Two cases of amineptine dependence. Amineptine dependence. Detection of patients at risk. Report of eight cases. Analysis of cases. An evaluation of the official cooperative survey of the Regional Centers of Pharmacovigilance.

Amineptine dependence and iatrogenic acne. Review of the literature apropos of a case. Ann Med Psychol Paris ; — Amineptine dependence and schizophrenia. Acne due to amineptine abuse. J Eur Acad Dermatol Venereol. World Health Organization Technical Series Perera I, Lim L.

Amineptine and midazolam dependence. Singapore Med J. Ahmed SH, Haq I. J Pak Med Assoc. A case of amineptine dependence. Treatment of depression in patients with alcohol or other drug dependence. A meta-analysis. Pettinati HM. Antidepressant treatment of co—occurring depression and alcohol dependence. Schuckit MA. Comorbidity between substance use disorders and psychiatric conditions. Volkow ND. The reality of comorbidity: depression and drug abuse.

Current status of co-occurring mood and substance use disorders: a new therapeutic target. Treatment of substance abusing patients with comborbid psychiatric disorders. Universal precautions revisited: managing the inherited pain patient. Opioid treatment of chronic pain in patients with addiction. J Pain Palliat Care Pharmacother. Casa Columbia Overview of brief intervention for risky substance use in primary care. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.

Subst Abus. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U. Preventive Services Task Force. Ann Intern Med. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcohol. A randomized controlled trial testing the efficacy of a brief cannabis universal prevention program among adolescents in primary care.

West J Emerg Med. These symptoms for other antidepressants are similar to the withdrawal symptoms for Prozac listed above but may occur in varying degrees of severity. Some medications cause more severe symptoms of discontinuation syndrome than others, primarily due to how quickly the drugs remove themselves from the body. On average, symptoms of discontinuation syndrome last for 1 to 2 weeks but may be present for up to a year, 9 depending on the medication and on how long the person has taken that medication.

In fact, fluoxetine is often used as a treatment for discontinuation syndrome when a person is ending the use of another SSRI medication. This is concerning when viewed in light of the research results mentioned above, which indicate that fluoxetine carries the same risk of discontinuation syndrome.

Since fluoxetine is often used to treat long-term mental health conditions such as OCD, discontinuation syndrome may be more severe for these patients than for patients who use Prozac in the short term to manage withdrawal symptoms. Still, caution should be taken when discontinuing fluoxetine, and ending the use of any antidepressant should be done under the supervision of a physician.

The types of treatment used to end dependence on fluoxetine depend on the circumstances surrounding how the medication is used. For people who abuse Prozac or take it in an attempt to self-medicate, treatment should focus on any other substances that are abused along with fluoxetine and on the conditions that people are attempting to treat.

For example, a person taking fluoxetine as an appetite suppressant should receive treatment for the eating disorder associated with this use of the medication.

People who use fluoxetine and alcohol or fluoxetine and opioids together should receive treatment for abuse of those respective substances. As stated previously, people who want to end the use of medically prescribed fluoxetine should do so under the supervision of their physicians. Prozac should be tapered gradually until a person can function without the drug with no withdrawal symptoms.

The longer a person has taken Prozac, the longer it will take to taper off the medication. In some cases, this may take months or even over a year.

It is important to remember that as Prozac is tapered, the symptoms that the medication was used to treat may return. A person who used fluoxetine for major depressive disorder may experience symptoms of depression again. People with obsessive-compulsive disorder may experience more intrusive thoughts. These symptoms should be monitored and managed if they occur.

In some cases, a person may need to discuss the pros and cons of ending fluoxetine use with their physician, as ending the use of the drug may be worse than staying on it.

People who want to end Prozac use should also continue with other treatments that they have received for their respective conditions. Therapy, counseling, educational services, and social support should all be in place before a person begins to end Prozac use, just in case the symptoms of the condition reappear.

These services will help the person manage those symptoms as they taper the drug. If a person has not required services for a while due to the condition being stable, they should make sure to re-establish contact with service providers before tapering Prozac. On the whole, Prozac is a safe drug to use for the treatment of mental health conditions for which the FDA has approved it and on a short-term basis. Using Prozac to self-medicate can be dangerous, so Prozac should always be used under the supervision of a physician.

Long-term use of Prozac can cause drug dependence, so ending the use of Prozac should always be done under the supervision of a physician.

People who want to end Prozac use should not try to quit on their own but should seek help. Name Email Phone How can we help? Name This field is for validation purposes and should be left unchanged. Call Us: Prozac Addiction and Treatment. Table of Contents What is Prozac? What is Prozac and How is it Used? How Common is Prozac? Is Prozac a Controlled Substance? What are SSRIs? When pregnant, SSRIs may harm the baby. Prozac Misuse and Abuse. Happy Pills.

Wonder Drug. Bottled Smilies.